NEW YORK (GenomeWeb News) – Harvard Bioscience today said it has formed a co-marketing and -development agreement with Nanoentek under which Nanoentek’s Digital Bio and HBIO’s BTX units will distribute certain of each others products in the US and in Asia.
 
HBIO’s BTX Harvard Apparatus business will distribute a gene-delivery system in the US made by Digital Bio, a Nanoentek segment.
 
Digital Bio in return will distribute BTX’s electroporation products in Asia.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.